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Abstract
Background: In 2012 the age-standardized acute myocardial infarction (AMI) mortality rate was in the federal state
Saxony-Anhalt 67 deaths per 100.000 whereas in Germany the AMI-rate was 47 deaths per 100.000. The rate in
Saxony-Anhalt was therefore 43 % above the national average. Many factors may explain this above-average AMI
mortality rate:
First, the prevalence of cardiovascular risk factors (e.g. arterial hypertension, diabetes mellitus, smoking) in
Saxony-Anhalt is the highest among all the Federal States of Germany. Second, structural health care for patients
with AMI is potentially deficient (e.g. insufficient number of percutaneous coronary intervention-centers or deficits
in the pre-hospital logistics of care). Third, the pre- and in-hospital process quality of health care for patients with
AMI is possibly insufficient (e.g. time to reperfusion therapy).
In July 2013 we established the regional myocardial infarction registry of Saxony-Anhalt (Regionales Herzinfarktregister
in Sachsen-Anhalt, RHESA). RHESA is a population-based registry in the eastern part of Germany.
Aims of RHESA are to calculate the AMI morbidity and mortality rates. Furthermore we study the factors that may
potentially influence these rates in Saxony-Anhalt.
Methods: RHESA is a population-based registry of patients with fatal or non-fatal AMI that was established in July 2013.
The registry population comprises inhabitants aged 25 years or more of the city of Halle (Saale) (n = 179.000) and
inhabitants of the rural district Altmark (n = 165.000) in the federal state Saxony-Anhalt, Germany.
Discussion: The main objectives of RHESA are to provide detailed estimates of the burden of AMI in Saxony-Anhalt
which is the federal state with the highest AMI mortality rate in Germany and to investigate factors that influence
morbidity and mortality rates due to AMI. Data collected in RHESA enable us to assess different levels of quality of
health care of patients with AMI (structural, process and outcome). RHESA provides for the first time estimates of the
burden of AMI in Saxony-Anhalt, and therefore contributes considerably to an improvement of the German Health
Monitoring that strives for a more valid extrapolation of the nationwide morbidity and mortality rates of AMI.
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Background
Cardiovascular diseases (CVD) are the leading causes of
death and morbidity in Europe. In 2012, CVD caused 47 %
of all deaths in Europe [1] and 40 % in Germany [2]. For
Germany a decrease in CVD mortality over the past
decades has been observed. However, an east–west and
north–south gradient of higher mortality in the eastern
and northern part is still present. For the year 2012, the
highest age-standardised death rates were observed in
Saxony-Anhalt, Mecklenburg-Western Pomerania, and the
lowest in Hamburg, Berlin, Baden-Wuerttemberg, and
Hesse [2].
Differences in mortality rates due to acute myocardial
infarction (AMI) across the federal states of Germany
are also present. The age-standardised AMI mortality
rate in 2012 was 67 deaths per 100.000 person-years in
Saxony-Anhalt, 43 % above the national average of 47
deaths per 100.000 [3].
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Many factors may explain the higher AMI mortality
rate in Saxony-Anhalt. First, the prevalence of cardiovas-
cular risk factors (diabetes mellitus, smoking, arterial
hypertension, obesity, increased waist circumference,
and metabolic syndrome) in Saxony-Anhalt is the
highest among all Federal States of Germany [4]. Second,
structural quality of health care for patients with AMI is
potentially inadequate, e.g. less percutaneous coronary
intervention-centers (PCI-centers), chest-pain units (CPU),
and cardiologists compared to the national average
(Table 1). Third, the pre- and in-hospital process quality of
health care for patients with AMI could be less suffi-
cient (e.g. patient delay, system delay, time to reperfusion
therapy) [5].
Currently, population-based event rates of AMI in
Germany are based on data from the region of Augsburg,
Bavaria (AMI Registry of the Cooperative Health Research
of the Region Augsburg, KORA [6]). Furthermore there
are some clinical registries like the Berlin Myocardial
Infarction Registry, BMIR [7]. Alternatively, source of
aggregate data for morbidity rates of AMI are from
diagnosis-related groups statistics and health insur-
ance funds, routinely collected data that are subject to
selection bias.
The regional myocardial infarction registry of Saxony-
Anhalt (Regionales Herzinfarktregister Sachsen-Anhalt,
RHESA) is a population-based registry of fatal and
non-fatal cases of myocardial infarction in this federal
state of Germany.
Primary aims of RHESA are to calculate AMI morbidity
and mortality rates in Saxony-Anhalt and to study
the factors that may potentially influence these rates.
Furthermore, by systematic follow-up of registered
AMI patients, survival and determinants of survival
are studied.
In particular RHESA enables us:
1) to assess quality of health care of AMI patients [8]
in terms of
– structure (related to number of PCI Center,
structure of emergency services [9])
– process (different time intervals: symptom onset
to first medical contact (FMC), FMC to
Diagnosis, FMC to reperfusion therapy, pain to
door, door to balloon [DTB])
– outcome (pre-, −in-hospital AMI mortality,
mortality of AMI survivors, re-infarction rate)
2) to compile a risk- and care-profile of the
AMI-patients.
3) to assess regional disparities in AMI management
(rural vs. urban region)
This paper presents the design of the Regional
Myocardial Infarction Registry of Saxony-Anhalt (RHESA).
Methods/Design
Study design
RHESA is a population-based registry of patients with
AMI that was established in July 2013 and is conducted
by the Institute of Medical Epidemiology, Biostatistics
and Informatics at the Martin-Luther-University Halle-
Wittenberg, Germany.
Study population
The registry population comprises inhabitants aged 25 years
or more of the city of Halle (Saale) (n = 179.000; population
density: 1.326 per km2) and inhabitants of the rural district
Altmark (n = 165.000, population density: 35 per km2)
in the federal state Saxony-Anhalt, Germany (Fig. 1).
Collaborating institutions in the region are: 16 hospitals,
three health departments (Halle, Salzwedel, and Stendal),
the rescue coordination centre in Halle (Saale), the rescue
service “Johanniter” in Stendal, 16 residence registration
offices, and approx. 550 physicians.
Data collection
Figure 2 shows the stepwise description of the RHESA
data collection.
Non-fatal events
According to the “Third universal definition of myocardial
infarction” of the European Society of Cardiology we
define an AMI if there is evidence of myocardial necrosis
in a clinical setting consistent with acute myocardial
ischaemia. “Under these conditions is an acute myocardial
infarction defined as: Detection of a rise and/or fall of
cardiac biomarker values (preferably cardiac troponin
[cTn]) with at least one value above the 99th percentile
upper reference limit and with at least one of the following:
symptoms of ischaemia, new or presumed new significant
ST-segment–T wave changes or new left bundle
branch block, development of pathological Q waves
in the ECG, imaging evidence of new loss of viable
myocardium or new regional wall motion abnormality,
identification of an intracoronary thrombus by angiography
or autopsy” [10].
All patients with a clinically confirmed AMI are asked
to give written consent to participate in the registry of
RHESA by the medical staff (physicians or study nurses)
Table 1 Number of chest pain units, PCI-centers, and
cardiologists per 100.000 inhabitants in Saxony-Anhalt and
Federal Republic of Germany [13]
Saxony-Anhalt Germany
Chest Pain Units 0,09 0,26
PCI Centers 0,94 1,06
Cardiologists 3,12 3,96
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of the collaborating hospitals. Trained physicians or study
nurses collect data with a hospital questionnaire during
patients’ hospitalization by medical record review. Data
include 1) personal data, 2) preexisting risk factors
and comorbidities, 3) medical treatments and interven-
tions during hospitalization, 5) clinical complications, 6)
medication before and during hospitalization and at hos-
pital discharge [see Additional file 1]. The questionnaire
was derived from the BMIR [7]. From potentially eligible
patients who refuse to participate, a hospital questionnaire
with anonymised data is filled in.
From each patient who consented to participate in
RHESA, an emergency protocol completed by an
emergency physician (mostly in the ambulance) is also
collected. Information from the emergency protocols
allows investigations into emergency management in the
prehospital phase. Items of interest are: 1) duration from
symptom onset until emergency call, 2) duration until the
arrival at the patient’s home, 3) duration of the medical
treatment of the emergency physician on site, 4) duration
until arrival at the hospital, 5) treatments and interven-
tions, and 6) medication.
Fig. 1 Region of Registry (Yellow = Germany, Grey = federal state Saxony-Anhalt, Black = registry region: City of Halle (Saale), Altmark)
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Fatal events
Fatal events are defined according to the registry of the
WHO-MONICA (Multinational MONItoring of trends
and determinants in CArdiovascular disease)/KORA
study [11].
The three health departments send anonymised death
certificates to RHESA monthly that contains at least one
of the following diagnoses: hypertension (ICD-10 I10),
ischaemic heart disease (ICD-10 I20-25), other CVD,
including sudden cardiac death (ICD-10 I30-I52),
atherosclerosis (ICD-10 I70), diabetes mellitus (ICD-10
E10-E11), dyslipidemia (ICD-10 I78), obesity (ICD-10
E66). Furthermore the health departments send a
physician’s questionnaire [see Additional file 2] to the
most recent treating physician or coroner. These
physicians send the filled physician’s questionnaire
back to RHESA. We use the information from the
death certificate and the physician’s questionnaire for
classifying events according to the MONICA diagnostic
category of coronary death. We classify four categories:
“definite acute myocardial infarction” (autopsy), “possible
coronary death” (acute symptoms, and a positive history
of ischaemic heart disease [angina pectoris or previous
myocardial infarction or diagnosed ischaemic heart
disease]), “no acute myocardial infarction” (where another
diagnosis has been made (clinically or at autopsy), or
“fatal cases with insufficient data” (cases with no autopsy,
no history of typical or atypical or inadequately described
symptoms, no previous history of ischaemic heart dis-
ease and no other diagnosis) [12]. Details of defini-
tions of the variables are given in the respective design
papers [12, 11].
For the study of the survival status among AMI patients
who gave consent for follow-up and re-contact, the regis-
tration offices are contacted at different points in time. For
patients who have died, the responsible health department
sends the corresponding death certificate to RHESA.
Follow up
Since November 2014, we have been conducting tele-
phone interviews with participating AMI patients
(RHESA-CARE-Study). We collect data about cardiovas-
cular risk factors, medication and utilization of medical
services before and after the AMI, psychosocial factors
(socioeconomic and employment status, depression), and
participation in cardiovascular rehabilitation.
Quality assurance
We established different methods for quality assurance.
1) Standard Operating Procedures
To reduce variability in data collection, all reporting
institutions (hospitals, health departments) fill in all
questionnaires according to standard operating
procedures.
2) Data-Completeness
All records are regularly checked for errors and
inconsistencies.
3) Case-Reporting-Completeness
To check the completeness of case-reporting,
we compare the number of all patients who were
annually discharged from our 16 collaborating
hospitals with diagnosis of AMI (ICD-10: I20, I21)
with the number of registered cases.
Fig. 2 Schema of RHESA data collection. *completed with a Physician Questionnaire
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– Twice a month, every reporting hospital receives a
RHESA reminder with the slogan: “Already reported?”
– Once a month, every reporting hospital receives a
diagram with the number of incoming case reports
– Twice a year, the participating centres receive a
detailed report from RHESA. The report comprises
data on diagnostics, treatments, medications, and
time intervals (e.g. DTB). Furthermore hospitals can
compare their own results with those from other
centres.
– Once a year, we organize a conference with all
reporting hospitals.
Statistical analyses
We calculate several epidemiologic frequency measures
of interest. First, we calculate age- and sex-specific AMI
morbidity rates (per 100.000 person-years) by dividing
the number of incident and recurrent cases of AMI by the
mid-year population of Saxony-Anhalt in the respective
calendar year. Second, we calculate age- and sex-specific
AMI mortality rates (per 100.000 person-years) by dividing
the total number of cases of AMI followed by death by the
mid-year population of Saxony-Anhalt in the respective
calendar year. Third, we calculate age- and sex-specific
case fatality rates (in %) by dividing the number of cases of
AMI followed by death within a defined time interval of
onset (before being admitted to hospital, within 24 h and
within 28 days) by the total number of cases of AMI.
Statistical analyses are performed using SAS 9.4 (SAS
Institute, Cary, NC, USA).
Ethics
RHESA was approved by the Ethics Committee of the
Medical Faculty of the Martin-Luther-University
Halle-Wittenberg and by the State Data Protection and
Privacy Commissioner of Saxony-Anhalt.
Discussion
The main objectives of RHESA are to provide detailed
estimates of the burden of AMI in Saxony-Anhalt and to
investigate factors that influence morbidity and mortality
rates due to AMI. Data collected in RHESA enable us to
assess different levels of quality of health care of patients
with AMI (structural, process and outcome).
In particular, data on event rates of AMI have important
implications for the allocation of funds for the improve-
ment of the effectiveness of management and health care
provision of patient who suffered from AMI (with diagnosis
of AMI) and the strengthening of epidemiological research
in the area of the health care services.
Finally, for the first time RHESA provides estimates of
the burden of AMI in Saxony-Anhalt, which is the federal
state with the highest AMI mortality rate in Germany,
and therefore RHESA contributes considerably to an
improvement of the German Health Monitoring that
strives for a more valid extrapolation of the nationwide
morbidity and mortality rates of AMI.
Additional files
Additional file 1: Hospital questionnaire.
Additional file 2: Physician’s questionnaire.
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